Unraveling Receptor Stoichiometry Using Bret by James H. Felce & Simon J. Davis
The first and arguably most important ques-
tion that could be asked about the biology of 
any protein is: does it function alone? Cell 
surface receptors present special problems 
for stoichiometric analysis because, being 
located within lipid bilayers, they are often 
very hydrophobic, which means that once 
isolated they can exhibit a strong tendency 
to aggregate. A very welcome development, 
therefore, has been the advent of in situ 
methods for probing receptor organization, 
the most important of which are presently 
based on resonance energy transfer. Our 
first bioluminescence resonance energy 
transfer (BRET) experiments were, how-
ever, inconclusive since both monomeric 
and dimeric receptors gave high levels of 
energy transfer (James et al., 2006). It was 
only with the application of theoretical 
principles first developed for (Fung and 
Stryer, 1978; Wolber and Hudson, 1979), 
and then used in (Kenworthy and Edidin, 
1998), Förster resonance energy transfer 
(FRET) experiments that we could use 
BRET to confidently distinguish between 
monomers and dimers.
We were very keen to test G protein-
coupled receptors (GPCRs) using the new 
approach given the great interest in these 
important proteins forming constitutive 
oligomeric complexes (Angers et al., 2000; 
Ramsay et al., 2002; Babcock et al., 2003). 
This seemed unlikely to us firstly because, 
structurally, GPCRs are ideally configured 
for functioning autonomously (Meng 
and Bourne, 2001) and, secondly, because 
functional autonomy explains the remark-
able evolutionary success (Schiöth and 
Fredriksson, 2005) of this very large fam-
ily of receptors. We were initially ignorant 
of the extent to which BRET was used to 
buttress the “GPCRs as oligomers” concept 
(Pfleger and Eidne, 2005), but when our ini-
tial analyses of human β
2
-adrenergic (β
2
AR) 
and mouse cannabinoid (mCannR2) 
receptors yielded the “BRET signatures” of 
monomers (James et al., 2006), we had to 
confront this body of data. The resulting 
controversy (Bouvier et al., 2007; James and 
Davis, 2007a,b; Salahpour and Masri, 2007) 
seems to have prompted the development 
of other, more complicated approaches. 
Here, we describe our experiences using 
BRET and briefly consider the merits of 
these alternative approaches.
Once is nOt enOugh
Like all resonance energy transfer-based 
methods, BRET is based on the principle 
of non-radiative energy transfer (Förster, 
1948). In this case excitation energy is passed 
from a luminescent donor (luciferase) to 
a fluorescent acceptor protein, typically a 
modified variant of green fluorescent pro-
tein (GFP) such as yellow fluorescent pro-
tein or GFP2. Many early studies of surface 
receptors, particularly GPCRs, employed 
“conventional” BRET assays developed for 
analyzing interacting soluble proteins, in 
which donor- and acceptor-fused recep-
tors are expressed at a single, fixed ratio, 
and BRET efficiency (BRET
eff
) is measured 
as relative to controls (Angers et al., 2000; 
Ramsay et al., 2002; Babcock et al., 2003). 
These early studies were largely unanimous 
in concluding that the receptors in question 
form homo- and hetero-oligomeric interac-
tions and were significant in establishing the 
oligomeric GPCR paradigm (Pfleger and 
Eidne, 2005). We initially used this assay 
to determine whether an immune protein, 
CD80, forms dimers at the cell surface as 
implied by our crystal structure (Ikemizu 
et al., 2000), and were pleased to see strong 
energy transfer in our first experiments. 
However, the closely related protein, CD86, 
which is a monomer, also yielded high levels 
of energy transfer – as much as 25% of the 
levels obtained for covalent homodimers 
(James et al., 2006). We suspected that this 
was “background” energy transfer arising 
from random interactions within the mem-
brane, a view strengthened by analysis of a 
second monomer, CD2. We concluded that 
conventional BRET assays could be prob-
lematic for measuring receptor organiza-
tion in membranes because, within the 
crowded two-dimensional plane of the cell 
membrane, the signal arising from random 
interactions can reach significant levels.
theOretical wOrk-arOunds
Theoretical considerations (Fung and Stryer, 
1978; Wolber and Hudson, 1979; Kenworthy 
and Edidin, 1998) have predicted that the 
dependence of FRET on total and relative 
donor and acceptor concentrations differs 
systematically for specific and non-specific 
energy transfer. Applied to BRET in “type 
1”experiments, total protein concentration 
is held constant and the acceptor/donor 
ratio increased by replacing donors with 
acceptors (Figure 1A; James et al., 2006). In 
this context, BRET
eff
 for monomers is inde-
pendent of the acceptor/donor ratio above 
a certain threshold because donors always 
experience the same “acceptor environ-
ment.” For oligomers, however, replacing 
donors with acceptors reduces the frac-
tion of donor–donor complexes, convert-
ing them into BRET-productive pairs and 
increasing BRET
eff
. In “type 2” experiments 
(Figure 1B; James et al., 2006) total protein 
density is varied at constant acceptor/donor 
ratio. For monomeric proteins BRET
eff
 var-
ies linearly with total surface density for low 
expression levels, tending to zero at very low 
densities. Conversely, for constitutive oligo-
meric proteins BRET
eff
 is largely constant 
because expression itself is generally reli-
ant on oligomerization. However, at high 
densities, BRET
eff
 increases due to random 
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interactions of the oligomers within the 
membrane. For this reason it is inappropri-
ate to draw any conclusions from the gradi-
ent of the slope for BRET
eff
 versus expression 
level as, e.g., in Ramsay et al. (2002).
Using these new types of BRET experi-
ments we readily distinguished well-known 
monomeric and dimeric Type I membrane 
proteins, and even confirmed that CD80 
forms apparently transient dimers at the cell 
surface, as implied by analytical ultracen-
trifugation (Ikemizu et al., 2000). Applied 
to two GPCRs, β
2
AR and mCannR2, these 
assays yielded the unambiguous “BRET sig-
natures” of monomers (James et al., 2006). 
We also showed that the GABAβ receptor, 
a bona fide GPCR dimer, gave data charac-
teristic of dimers and that transfer of the 
cytoplasmic domain of GABAβR2 to β
2
AR 
converted monomer-like into dimer-like 
behavior. As expected, since β
2
AR and 
other GPCRs were widely believed to form 
homo- and hetero-dimers (reviewed in 
Bouvier, 2001), these findings were con-
troversial (Bouvier et al., 2007; James and 
Davis, 2007a,b; Salahpour and Masri, 2007).
alternative assays
Broadly speaking there is now consensus that 
conventional, single-ratio BRET experiments 
are inadequate to the task of assigning recep-
tor stoichiometry. However, although type 1 
and 2 BRET and FRET experiments are done 
occasionally (e.g., Kenworthy and Edidin, 
1998; Meyer et al., 2006), these approaches 
are not widely used. Instead, the so-called 
BRET “saturation” assay first used in 2002 
(Figure 1C; Mercier et al., 2002) remains 
popular (Contento et al., 2008; Ayoub and 
Pfleger, 2010). In this approach, donor num-
bers are kept constant and acceptor expres-
sion systematically increased. Under such 
conditions BRET
eff
 for a monomeric protein 
is linearly related to acceptor expression level, 
whereas for oligomers the relationship is 
hyperbolic. The problem therefore becomes 
one of distinguishing between two increas-
ing signals, which we would expect to be 
more difficult than distinguishing between 
increasing versus non-increasing signals, as 
in type 1 BRET assays (James et al., 2006). 
The problem becomes more acute for tran-
sient oligomers whose signals emerge from 
monomer/dimer equilibria, which is par-
ticularly relevant now that GPCRs are being 
claimed to transiently dimerize (Hern et al., 
2010; Lambert, 2010; Kasai et al., 2011).
A second, newer assay, the “BRET com-
petition” assay, presents subtler problems. 
In this assay, untagged “competitor” recep-
tors are co-transfected with acceptor- and 
donor-tagged proteins, leading to reduced 
BRET
eff
 for oligomers and unchanged 
BRET
eff
 for monomers (Veatch and Stryer, 
1977). In our experience, expression 
of untagged competitors often reduces 
expression of their tagged equivalents 
(Felce et al., unpublished data), includ-
ing monomer control proteins, reducing 
BRET
eff
 artifactually. In BRET competi-
tion assays of GPCR homo- and heter-
odimerization (e.g., Terrillon et al., 2003; 
Guo et al., 2008), reduced energy transfer 
in the presence of untagged competitors 
is always observed, yet the issue of surface 
density is never addressed. Such approaches 
have their place but the absolute levels of 
tagged protein must be factored in to avoid 
ambiguity.
Figure 1 | Principles of BreT assays. (A) In a type 1 BRET assay the 
acceptor/donor ratio is increased but surface density is kept constant. The 
increase in acceptor/donor ratio is obtained by exchanging a donor for an 
acceptor (the change is indicated within the red circle). For simplicity, BRETeff is 
defined here as the ratio of the numbers of fluorescent acceptors and 
luminescent donors. In the examples shown, for the monomer (top) BRETeff is 
unchanged (3/3 versus 4/4), whereas for the dimer (bottom) the ratio increases 
from 2/4 to 3/3 as the fraction of productive dimers increases. (B) In a type 2 
BRET experiment, the acceptor/donor ratio is kept constant and surface 
density is varied, in this case by a factor of two. Due to the increase in 
monomer density (top) the likelihood of random collisions increases, and 
BRETeff increases from 2/3 to 5/6. For constitutive dimers (bottom), however, 
BRETeff is largely unchanged, increasing from 2/4 to 5/8, because the likelihood 
of dimerization doesn’t change. Only random interactions of dimers (arrow) 
contribute to increases in BRETeff (in reality, of course, these contributions will 
be significantly smaller than the effects of dimerization). (C) In the “saturation” 
BRET assay, the acceptor/donor ratio is increased by keeping donor numbers 
constant and increasing the numbers of acceptors. In the examples shown, 
BRETeff for monomers (top) and dimers (bottom) both increase upon addition of 
one or two extra acceptors, respectively (from 4/4/  to 5/4 for the monomer, 
and from 2/4 to 5/4 for the dimer). This is due to the increased random 
interactions of monomers, and increased formation and random interactions 
of dimers. We expect assays in which BRETeff always increases to be more 
easily misinterpreted than assays in which changes in BRETeff vary 
systematically with receptor stoichiometry.Fluorescing and non-fluorescing 
acceptor molecules are shown as green and white circles, respectively, and 
donors as blue circles. The BRET-permissible area surrounding donors is 
represented as a blue halo.
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is presently significantly better than that 
of in situ single-molecule imaging tech-
niques, which, even in fixed cells, is limited 
to ∼20 nm (Moerner, 2012). We think that 
it will be some time before BRET, rigorously 
applied, is surpassed as a probe of receptor 
stoichiometry.
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2005), saturation (Sohy et al., 2009), and 
competition (Terrillon et al., 2003) BRET 
assays have all been used to support claims 
for GPCR heterodimerization.
cOncluding remarks
There is now implicit agreement that sin-
gle measurements of BRET
eff
 are unhelpful 
because the contribution of random inter-
actions to the signal is not easily discerned. 
Similarly, the notion that varying expression 
levels can also give potentially misleading 
changes in BRET
eff
 is taking root, prompt-
ing new methods such as “Third-part BRET,” 
which seek to control for background effects 
in single measurements. The problem with 
these approaches is their heavy reliance on 
negative controls, which as we have discussed 
are often difficult to choose. We are surprised 
that the relatively simple approaches involv-
ing systematic variations of the acceptor/
donor ratio, or of expression level alone, are 
not more widely used. We emphasize once 
again that the key to these methods is their 
exclusive reliance on the measurable, intrin-
sic behavior of populations of receptors dif-
fusing in the plane of the membrane, and 
that an important advantage is that the assays 
are effectively control-independent.
Overall, the question of whether or not 
GPCRs generally form oligomers remains 
unsettled. The notion that they do is driven 
not only by BRET experiments, but also by 
FRET (Albizu et al., 2010; Cunningham 
et al., 2012), photon-counting analyses 
(Kilpatrick et al., 2012), and single-molecule 
microscopy (Hern et al., 2010; Kasai et al., 
2011). We are seeking to test our BRET-
based conclusions using super-resolution 
imaging, and to address GPCR stoichiom-
etry at the family level using type 1 BRET 
and other experiments implemented in a 
high throughput setting.
Despite the controversies over its use 
BRET still has a very bright future. New 
luciferases, such as Rluc2 and Rluc8 (De 
et al., 2007), and acceptor fluorophores, 
such as Venus (Kocan et al., 2008), mOrange 
(De et al., 2009), and Renilla GFP (RGFP; 
Kamal et al., 2009), are brighter and offer 
up the possibility of in vivo studies (De 
et al., 2009). Future developments in BRET-
quantum dot (Wu et al., 2011; Quiñones 
et al., 2012) and BRET-FRET (Carriba et al., 
2008) assays will also advance the technique. 
The effective resolution of resonance energy 
transfer methods in live cells, i.e., ∼10 nm, 
cOntrOl prOblems
An important factor complicating some 
BRET experiments is the heterogeneity 
of protein distribution, emphasizing the 
importance of the careful choice of con-
trols. The cell membrane is a highly com-
plex environment (Kusumi et al., 2011), and 
evidence is mounting that complex regula-
tory processes may control the localization 
and movement of integral membrane pro-
teins, including GPCRs (Meyer et al., 2006; 
Nikolaev et al., 2010; Weigel et al., 2011). 
The potential for proteins to be localized 
to different areas of the cell surface, or to 
have different constraints on their traffick-
ing, has important implications for data 
interpretation. This applies especially to 
“irrelevant” controls, which should have 
similar hydrodynamic diameter to the pro-
tein of interest but be sufficiently unrelated 
to not form specific associations (Angers 
et al., 2000; Mercier et al., 2002). However, 
such proteins may not be similarly localized 
at the membrane. For example, if the con-
trol protein exhibits strong association with 
the cytoskeleton but the protein of interest 
does not, BRET
eff
 will be lower in the control 
experiment than it would be if the two pro-
teins co-localized but randomly interacted. 
Similarly, control proteins may be expressed 
at different total densities or have different 
stoichiometries, adding further complica-
tions. Without knowing their behavior and 
expression characteristics in detail, it is dif-
ficult to select appropriate controls.
Approaches in which acceptors are 
recruited to donor-tagged proteins of inter-
est are especially dependent on control 
choice. In “Third-party BRET” (Kuravi et al., 
2010), a membrane-associated acceptor is 
chemically recruited to an untagged recep-
tor of interest and BRET
eff
 increases if the 
untagged receptor is a dimer that brings with 
it a donor-tagged receptor, the goal being to 
avoid the complication of varying expres-
sion levels. However, if the receptors are co-
localized but do not interact, then acceptor/
untagged receptor dimerization could recruit 
the acceptor to an area of greater donor 
concentration, increasing BRET
eff
 without 
genuine association. Similar arguments 
apply to GPCR-Heteromer Identification 
Technology (GPCR-HIT; Pfleger, 2009; 
Mustafa and Pfleger, 2011). For this reason, 
no conclusively reliable BRET-based assay for 
heterodimers presently exists. Despite these 
difficulties, conventional (Pfleger and Eidne, 
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